The new Dyevert Plus EZ.....has seen a rapid adoption by physicians in Jan/Feb 2019
![]()
Previous reporting periods also show a qter on qter increase in the number of units sold..
![]()
it takes some time to convince Hospitals of the benefits ( $ ) ...let alone the lives they may
save...lol Regardless ...Hospitals purchases have been increasing with repeat orders as well
as signing on new hospitals ...so therefore we have a growing sales
![]()
also since the deal with Premier Group OSP has established a Market share for CKI events
for New hospitals that equate 55% for GPO 1 and 47% for GPO 2
![]()
DYOR and aimo...glta
- Forums
- ASX - By Stock
- OSP
- Ann: DyeVert Clinical Data Featured at US Scientific Conferences
Ann: DyeVert Clinical Data Featured at US Scientific Conferences, page-4
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online